title: Low serum HDL-cholesterol concentrations in mid-life predict late-life cognitive impairment in type 2 diabetes: The Fremantle diabetes study.
abstract: In a study involving patients with type 2 diabetes assessed annually over 5years, serum HDL-cholesterol was the sole mid-life metabolic predictor of late-life cognitive impairment.
authors.affiliation: School of Medicine & Pharmacology, University of Western Australia. Electronic address: david.bruce@uwa.edu.au.
authors.forename: David G
authors.initials: DG
authors.lastname: Bruce
authors.affiliation: School of Medicine & Pharmacology, University of Western Australia.
authors.forename: Wendy A
authors.initials: WA
authors.lastname: Davis
authors.affiliation: School of Medicine & Pharmacology, University of Western Australia.
authors.forename: Timothy M E
authors.initials: TME
authors.lastname: Davis
mesh_terms: D000367:Age Factors; D017668:Age of Onset; D000368:Aged; D000369:Aged, 80 and over; D008076:Cholesterol, HDL / Q000097:blood*; D060825:Cognitive Dysfunction / Q000097:blood / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology* / Q000523:psychology*; D005260:Female; D006801:Humans; D052456:Hypoalphalipoproteinemias / Q000097:blood / Q000150:complications / Q000453:epidemiology* / Q000523:psychology; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012307:Risk Factors
chemical_list: D008076:Cholesterol, HDL
keywords: Cognitive impairment; HDL cholesterol; Longitudinal study; Type 2 diabetes